These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1645666)

  • 1. Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging.
    Lekakis J; Vassilopoulos N; Psichoyiou H; Athanassiadis P; Gerali S; Kostamis P; Moulopoulos S
    Eur J Nucl Med; 1991; 18(3):225-6. PubMed ID: 1645666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of adriamycin cardiotoxicity with indium-111 labeled antimyosin monoclonal antibody imaging.
    Yamada T; Matsumori A; Tamaki N; Morishima S; Watanabe Y; Yonekura Y; Endo K; Konishi J; Kawai C
    Jpn Circ J; 1991 Apr; 55(4):377-83. PubMed ID: 2046143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?
    Jain D; Zaret BL
    J Nucl Med; 1990 Dec; 31(12):1970-4. PubMed ID: 2266395
    [No Abstract]   [Full Text] [Related]  

  • 5. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity.
    Carrió I; Estorch M; Berná L; López-Pousa J; Tabernero J; Torres G
    J Nucl Med; 1995 Nov; 36(11):2044-9. PubMed ID: 7472595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimyosin positivity in doxorubicin cardiotoxicity: earlier than the conventional evidence.
    Narula J; Strauss HW; Khaw BA
    J Nucl Med; 1993 Sep; 34(9):1507-9. PubMed ID: 8355071
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
    Estorch M; Carrió I; Martínez-Duncker D; Berná L; Torres G; Alonso C; Ojeda B
    J Clin Oncol; 1993 Jul; 11(7):1264-8. PubMed ID: 8315423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer.
    Estorch M; Carrió I; Berná L; Martínez-Duncker C; Alonso C; Germá JR; Ojeda B
    J Nucl Med; 1990 Dec; 31(12):1965-9. PubMed ID: 2266394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.
    Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
    Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical role of indium-111 antimyosin imaging.
    Bhattacharya S; Lahiri A
    Eur J Nucl Med; 1991; 18(11):889-95. PubMed ID: 1752262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance.
    Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL
    Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
    Perik PJ; Lub-De Hooge MN; Gietema JA; van der Graaf WT; de Korte MA; Jonkman S; Kosterink JG; van Veldhuisen DJ; Sleijfer DT; Jager PL; de Vries EG
    J Clin Oncol; 2006 May; 24(15):2276-82. PubMed ID: 16710024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: a case series.
    Ku GY; De Lima Lopes G; Chang AY
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):174-9. PubMed ID: 21585698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity.
    Lopez M; Vici P
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):55-60. PubMed ID: 9768825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children.
    Kremer LC; Tiel-van Buul MM; Ubbink MC; Offringa M; Ottenkamp J; Olmos RV; Voûte PA
    J Clin Oncol; 1999 Apr; 17(4):1208. PubMed ID: 10561180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.
    Bulten BF; Verberne HJ; Bellersen L; Oyen WJ; Sabaté-Llobera A; Mavinkurve-Groothuis AM; Kapusta L; van Laarhoven HW; de Geus-Oei LF
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):957-67. PubMed ID: 26400150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of indium-111-labeled antimyosin monoclonal antibody in murine experimental viral myocarditis.
    Yamada T; Matsumori A; Watanabe Y; Tamaki N; Yonekura Y; Endo K; Konishi J; Kawai C
    J Am Coll Cardiol; 1990 Nov; 16(5):1280-6. PubMed ID: 2172346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radionuclide ventriculography detects early anthracycline cardiotoxicity in children with Hodgkin lymphoma.
    Tantawy AA; Elmasry OA; Shaaban M; Toaima DN; El Shahat AM
    J Pediatr Hematol Oncol; 2011 May; 33(4):e132-7. PubMed ID: 21516011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.